首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1741288

胸膜疾病市場按疾病類型、診斷工具、治療方法、最終用戶和地區分類

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年胸膜疾病市場規模為 57.6 億美元，到 2032 年將達到 93.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	57.6億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	7.20%	2032年價值預測	93.7億美元

胸膜疾病涵蓋多種影響胸膜（包裹肺部的薄膜）的疾病。這些疾病會對呼吸功能和整體健康產生重大影響。胸膜透過提供潤滑並使呼吸順暢，在維持肺部結構和功能完整性方面發揮著至關重要的作用。胸膜疾病的誘因多種多樣，例如感染疾病、發炎、腫瘤以及接觸有害物質。常見的胸膜疾病包括胸膜炎、胸腔積水、氣胸和間皮瘤。識別症狀、準確診斷並實施適當的治療策略，對於管理和改善全球範圍內受這些棘手胸膜疾病影響患者的預後至關重要。多年來，全球胸膜疾病市場一直穩定成長，這得益於吸菸、結核病和轉移等相關風險因素的盛行率不斷上升。此外，影像技術和雷射治療等診斷和治療方法的重大技術進步也進一步推動了市場的成長。

市場動態：

預計在預測期內，協議等無機策略的日益普及也將推動市場成長。例如，2020年11月，製藥公司工業 Co., Ltd.與臨床階段生物製藥公司Lung Therapeutics, Inc.宣佈在日本簽署獨家授權合約，Lung Tx將開發用於治療局部胸膜積液的重組人單鏈尿激酶型胞漿素原原活化劑。

然而，在預測期內，認知度低、診斷延遲、診斷工具和治療成本高以及缺乏專業知識和資源將阻礙全球胸膜疾病市場的成長。

本研究的主要特點

本報告對全球胸膜疾病市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模和年複合成長率(CAGR)。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球胸膜疾病市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球胸膜疾病市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球胸膜疾病市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.20%	2032 Value Projection:	USD 9.37 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The Global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Respiratory diseases
- Restraints
Limited Availability of Expertise and Resources
- Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2032, (US$ Billion)
Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

胸膜疾病市場按疾病類型、診斷工具、治療方法、最終用戶和地區分類

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場動態：

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

第4章。全球胸膜疾病市場-冠狀病毒（COVID-19）大流行的影響

5. 2020-2032 年全球胸膜疾病市場（依疾病類型）

6. 2020-2032 年全球胸膜疾病市場（依診斷工具分類）

7. 全球胸膜疾病市場（依治療方法），2020-2032 年

8. 2020 年至 2032 年全球胸膜疾病市場（依最終使用者分類）

9. 2020-2032 年全球胸膜疾病市場（按地區）

第10章競爭格局

第 11 章章節

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

胸膜疾病市場按疾病類型、診斷工具、治療方法、最終用戶和地區分類

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場動態：

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章市場動態、法規與趨勢分析

第4章。全球胸膜疾病市場-冠狀病毒（COVID-19）大流行的影響

5. 2020-2032 年全球胸膜疾病市場（依疾病類型）

6. 2020-2032 年全球胸膜疾病市場（依診斷工具分類）

7. 全球胸膜疾病市場（依治療方法），2020-2032 年

8. 2020 年至 2032 年全球胸膜疾病市場（依最終使用者分類）

9. 2020-2032 年全球胸膜疾病市場（按地區）

第10章 競爭格局

第 11 章 章節

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

第1章調查目的與前提條件

第2章市場展望

第10章競爭格局

第 11 章章節